NTB Financial’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,895	Closed	-$235K	–	144
2022 Q1	$235K	Hold	6,895	–	–	0.17%	134
2021 Q4	$266K	Buy	+6,895	New	+$266K	0.19%	121